Covishield, Covaxin likely to be capped at Rs 275 after regular market approval
Shortpedia
Content Team
Image Credit: shortpdia
The price of Covishield and Covaxin, the Covid vaccines which are expected to soon get regular market approval from India's drug regulator, is likely to be capped at Rs 275 per dose plus an additional service charge of Rs 150, official sources said. According to them, the National Pharmaceutical Pricing Authority (NPPA) has been directed to start working towards capping the price to make the vaccines affordable.
